Collection's Items (Sorted by Submit Date in Descending order): 101 to 120 of 1011
| Issue Date | Title | Author(s) |
| 2024-07 | Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape | Kumar, Gautam |
| 2024-06 | Tackling nontuberculous mycobacteria by repurposable drugs and potential leads from natural products | Kumar, Gautam |
| 2024-08 | Tackling multi-drug resistant fungi by efflux pump inhibitors | Kumar, Gautam |
| 2024-09 | Identification and benchmarking of myokinasib-ii as a selective and potent chemical probe for exploring mlck1 inhibition | Kumar, Gautam |
| 2024-11 | Natural peptides and their synthetic congeners acting against Acinetobacter baumannii through the membrane and cell wall: latest progress | Kumar, Gautam |
| 2024-11 | Naturally occurring organosulfur for treating metabolic disorders and infectious diseases | Kumar, Gautam |
| 2023-02 | Computational search for potential covid-19 drugs from ayurvedic medicinal plants to identify potential inhibitors against sars-cov-2 targets | Murugesan, Sankaranarayanan |
| 2023-01 | Design, synthesis, and antimycobacterial evaluation of novel tetrahydroisoquinoline hydrazide analogs | Murugesan, Sankaranarayanan |
| 2022-12 | Spotlight on 4-substituted quinolines as potential anti-infective agents: Journey beyond chloroquine | Murugesan, Sankaranarayanan |
| 2023-03 | Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor – An in-silico analysis | Murugesan, Sankaranarayanan |
| 2023-04 | Retrospective review of chromane analogues as anti-protozoal leads: a decade's worth of evolution | Murugesan, Sankaranarayanan |
| 2023-02 | Drug repurposing: an effective tool in modern drug discovery | Murugesan, Sankaranarayanan |
| 2023-04 | Advances in the synthesis of diarylpyrimidine as potent non-nucleoside reverse transcriptase inhibitors: biological activities, molecular docking studies and structure-activity relationship: a critical review | Murugesan, Sankaranarayanan |
| 2023-07 | Design, synthesis, and biological evaluation of novel quinazolin-4(3h)-one-based histone deacetylase 6 (hdac6) inhibitors for anticancer activity | Murugesan, Sankaranarayanan |
| 2022-08 | Design, synthesis, graph theoretical analysis and molecular modelling studies of novel substituted quinoline analogues as promising anti-breast cancer agents | Murugesan, Sankaranarayanan |
| 2023-08 | Design, synthesis and biological evaluation of novel oxindole analogs as antitubercular agents | Murugesan, Sankaranarayanan |
| 2023 | Network analysis and in silico molecular modeling of bioactive compounds from sida cordifolia against NMDA receptor | Murugesan, Sankaranarayanan |
| 2023-11 | An in silico investigation to identify promising inhibitors for sars-cov-2 mpro target | Murugesan, Sankaranarayanan |
| 2023-11 | Effects of acute and repeated dose toxicity profiling of chelidonic acid in rats: in silico and in vivo evidence | Murugesan, Sankaranarayanan |
| 2022-09 | Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics | Murugesan, Sankaranarayanan |
Collection's Items (Sorted by Submit Date in Descending order): 101 to 120 of 1011
